scholarly journals Improving replicability using interaction with laboratories: a multi-lab experimental assessment

2021 ◽  
Author(s):  
Iman Jaljuli ◽  
Neri Kafkafi ◽  
Eliezer Giladi ◽  
Ilan Golani ◽  
Illana Gozes ◽  
...  

AbstractPhenotyping inbred and genetically-engineered mouse lines has become a central strategy for discovering mammalian gene function and evaluating pharmacological treatment. Yet the utility of any findings critically depends on their replicability in other laboratories. In previous publications we proposed a statistical approach for estimating the inter-laboratory replicability of novel discoveries in a single laboratory, and demonstrated that previous phenotyping results from multi-lab databases can be used to derive a Genotype-by-Lab (GxL) adjustment factor to ensure the replicability of single-lab results, for similarly measured phenotypes, even before making the effort of replicating the new finding in additional laboratories.The demonstration above, however, still raised several important questions that could only be answered by an additional large-scale prospective experiment: Does GxL-adjustment works in single-lab experiments that were not intended to be standardized across laboratories? With genotypes that were not included in the previous experiments? And can it be used to adjust the results of pharmacological treatment experiments? We replicated results from five studies in the Mouse Phenome Database (MPD), in three behavioral tests, across three laboratories, offering 212 comparisons including 60 involving a pharmacological treatment: 18 mg/kg/day fluoxetine. In addition, we define and use a dimensionless GxL factor, derived from dividing the GxL variance by the standard deviation between animals within groups, as the more robust vehicle to transfer the adjustment from the multi-lab analysis to very different labs and genotypes.For genotype comparisons, GxL-adjustment reduced the rate of non-replicable discoveries from 60% to 12%, for the price of reducing the power to make replicable discoveries from 87% to 66%. Another way to look at these results is noting that the adjustment could have prevented 23 failures to replicate, for the price of missing only three replicated ones. The tools and data needed for deployment of this method across other mouse experiments are publicly available in the Mouse Phenome Database.Our results further point at some phenotypes as more prone to produce non-replicable results, while others, known to be more difficult to measure, are as likely to produce replicable results (once adjusted) as the physiological body weight is.

2011 ◽  
Vol 11 (4) ◽  
pp. 481-489
Author(s):  
S. Krause ◽  
A. Obermayer

The public drinking water supply of southern Germany is characterized by a rather decentralized network. Due to the hydrogeological setting in these parts of Germany many of the small water works with an average capacity of 50 m3/h have to treat raw water extracted from karstic or cliffy aquifers. These raw waters tend to be contaminated with particles and pathogens acquired during snowmelt or after strong rainfalls. In the last decade ultrafiltration has become the technology of choice for the removal of the aforementioned contaminants. Flux decline caused by unanticipated membrane fouling is the main limitation for the application of ultrafiltration membranes. This paper describes how membrane fouling phenomena can be predicted by using a statistical approach based on data from large scale filtration systems in combination with field and lab experiments on raw water quality and membrane performance. The data defines water quality and respective fouling phenomena both in technical scale filtration plants and in lab experiments of eleven different raw waters. The method described here is more economically feasible for small water works when compared to typical pilot experiments that are used for high capacity water works.


2016 ◽  
Vol 113 (42) ◽  
pp. E6409-E6417 ◽  
Author(s):  
David G. McFadden ◽  
Katerina Politi ◽  
Arjun Bhutkar ◽  
Frances K. Chen ◽  
Xiaoling Song ◽  
...  

Genetically engineered mouse models (GEMMs) of cancer are increasingly being used to assess putative driver mutations identified by large-scale sequencing of human cancer genomes. To accurately interpret experiments that introduce additional mutations, an understanding of the somatic genetic profile and evolution of GEMM tumors is necessary. Here, we performed whole-exome sequencing of tumors from three GEMMs of lung adenocarcinoma driven by mutant epidermal growth factor receptor (EGFR), mutant Kirsten rat sarcoma viral oncogene homolog (Kras), or overexpression of MYC proto-oncogene. Tumors from EGFR- and Kras-driven models exhibited, respectively, 0.02 and 0.07 nonsynonymous mutations per megabase, a dramatically lower average mutational frequency than observed in human lung adenocarcinomas. Tumors from models driven by strong cancer drivers (mutant EGFR and Kras) harbored few mutations in known cancer genes, whereas tumors driven by MYC, a weaker initiating oncogene in the murine lung, acquired recurrent clonal oncogenic Kras mutations. In addition, although EGFR- and Kras-driven models both exhibited recurrent whole-chromosome DNA copy number alterations, the specific chromosomes altered by gain or loss were different in each model. These data demonstrate that GEMM tumors exhibit relatively simple somatic genotypes compared with human cancers of a similar type, making these autochthonous model systems useful for additive engineering approaches to assess the potential of novel mutations on tumorigenesis, cancer progression, and drug sensitivity.


2021 ◽  
Vol 111 (2) ◽  
pp. 687-719
Author(s):  
Erik Snowberg ◽  
Leeat Yariv

We leverage a large-scale incentivized survey eliciting behaviors from (almost) an entire undergraduate university student population, a representative sample of the US population, and Amazon Mechanical Turk (MTurk) to address concerns about the external validity of experiments with student participants. Behavior in the student population offers bounds on behaviors in other populations, and correlations between behaviors are similar across samples. Furthermore, non-student samples exhibit higher levels of noise. Adding historical lab participation data, we find a small set of attributes over which lab participants differ from non-lab participants. An additional set of lab experiments shows no evidence of observer effects. (JEL C83, D90, D91)


1985 ◽  
Vol 5 (7) ◽  
pp. 1795-1799
Author(s):  
D R Kaplan ◽  
B Bockus ◽  
T M Roberts ◽  
J Bolen ◽  
M Israel ◽  
...  

A recombinant plasmid containing a metallothionein promoter-polyoma middle T cDNA fusion was constructed and used to transfect NIH 3T3 cells. Transformed cells expressing middle T were injected into nude mice. Within 3 weeks, each mouse produced tumors containing middle T equivalent to that in 250 to 1,000 100-mm dishes of polyomavirus-infected cells. This middle T, partially purified by immunoaffinity chromatography, retained activity as measured by its ability to be phosphorylated in vitro. The combined approach of fusing strong promoters to genes of interest and utilizing nude mice to grow large quantities of cells expressing the gene provides a quick, inexpensive alternative to other expression systems.


2022 ◽  
pp. 95-110
Author(s):  
Doni Maryono ◽  
Rita Ambarwati

The pandemic has an impact on almost all sectors of people's lives, in the economic, political, and socio-cultural sectors. The government has implemented large-scale social restrictions (PSBB) as an effort to stop the spread of the COVID-19 virus. With the PSBB, it causes disruption to the hospital supply chain management. As a step to anticipate the hospital's impact on the PSBB, the hospital needs to evaluate the performance of supply chain management. The purpose of this chapter is to describe the performance evaluation of hospital supply chain management using a balanced scorecard approach. A new finding from this study is to measure the performance of hospitals experiencing various disruptions in their supply chain management caused by the COVID-19 pandemic with a balanced scorecard. The author concludes that measurements with the balanced scorecard approach can provide information about the performance of hospital supply chain management broadly in areas experiencing disruption due to the COVID-19 pandemic.


2018 ◽  
Vol 31 (14) ◽  
pp. 5731-5748 ◽  
Author(s):  
Casey D. Burleyson ◽  
Samson M. Hagos ◽  
Zhe Feng ◽  
Brandon W. J. Kerns ◽  
Daehyun Kim

Abstract The characteristics of Madden–Julian oscillation (MJO) events that strengthen and weaken over the Maritime Continent (MC) are examined. The real-time multivariate MJO (RMM) index is used to assess changes in global MJO amplitude over the MC. The MJO weakens at least twice as often as it strengthens over the MC, with weakening MJOs being twice as likely during El Niño compared to La Niña years and the reverse for strengthening events. MJO weakening shows a pronounced seasonal cycle that has not been previously documented. During the Northern Hemisphere (NH) summer and fall the RMM index can strengthen over the MC. MJOs that approach the MC during the NH winter typically weaken according to the RMM index. This seasonal cycle corresponds to whether the MJO crosses the MC primarily north or south of the equator. Because of the seasonal cycle, weakening MJOs are characterized by positive sea surface temperature and moist-static energy anomalies in the Southern Hemisphere (SH) of the MC compared to strengthening events. Analysis of the outgoing longwave radiation (OLR) MJO index (OMI) shows that MJO precipitation weakens when it crosses the MC along the equator. A possible explanation of this based on previous results is that the MJO encounters more landmasses and taller mountains when crossing along the equator or in the SH. The new finding of a seasonal cycle in MJO weakening over the MC highlights the importance of sampling MJOs throughout the year in future field campaigns designed to study MJO–MC interactions.


2020 ◽  
Vol 4 (14) ◽  
pp. 3357-3367 ◽  
Author(s):  
Rafet Basar ◽  
May Daher ◽  
Nadima Uprety ◽  
Elif Gokdemir ◽  
Abdullah Alsuliman ◽  
...  

Abstract Virus-specific T cells have proven highly effective for the treatment of severe and drug-refractory infections after hematopoietic stem cell transplant (HSCT). However, the efficacy of these cells is hindered by the use of glucocorticoids, often given to patients for the management of complications such as graft-versus-host disease. To address this limitation, we have developed a novel strategy for the rapid generation of good manufacturing practice (GMP)–grade glucocorticoid-resistant multivirus-specific T cells (VSTs) using clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9 (Cas9) gene-editing technology. We have shown that deleting the nuclear receptor subfamily 3 group C member 1 (NR3C1; the gene encoding for the glucocorticoid receptor) renders VSTs resistant to the lymphocytotoxic effect of glucocorticoids. NR3C1-knockout (KO) VSTs kill their targets and proliferate successfully in the presence of high doses of dexamethasone both in vitro and in vivo. Moreover, we developed a protocol for the rapid generation of GMP-grade NR3C1 KO VSTs with high on-target activity and minimal off-target editing. These genetically engineered VSTs promise to be a novel approach for the treatment of patients with life-threatening viral infections post-HSCT on glucocorticoid therapy.


1985 ◽  
Vol 5 (7) ◽  
pp. 1795-1799 ◽  
Author(s):  
D R Kaplan ◽  
B Bockus ◽  
T M Roberts ◽  
J Bolen ◽  
M Israel ◽  
...  

A recombinant plasmid containing a metallothionein promoter-polyoma middle T cDNA fusion was constructed and used to transfect NIH 3T3 cells. Transformed cells expressing middle T were injected into nude mice. Within 3 weeks, each mouse produced tumors containing middle T equivalent to that in 250 to 1,000 100-mm dishes of polyomavirus-infected cells. This middle T, partially purified by immunoaffinity chromatography, retained activity as measured by its ability to be phosphorylated in vitro. The combined approach of fusing strong promoters to genes of interest and utilizing nude mice to grow large quantities of cells expressing the gene provides a quick, inexpensive alternative to other expression systems.


Spinal Cord ◽  
1993 ◽  
Vol 31 (11) ◽  
pp. 722-729 ◽  
Author(s):  
P Fenollosa ◽  
J Pallares ◽  
J Cervera ◽  
F Pelegrin ◽  
V Inigo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document